[1]杨莎,翟瑄.早产儿脑损伤的治疗进展[J].临床小儿外科杂志,2021,20(09):876-880.[doi:10.12260/lcxewkzz.2021.09.015]
 Yang Sha,Zhai Xuan.Recent advances in the treatment of brain injury in premature infants[J].Journal of Clinical Pediatric Surgery,2021,20(09):876-880.[doi:10.12260/lcxewkzz.2021.09.015]
点击复制

早产儿脑损伤的治疗进展

参考文献/References:

1 Mwaniki MK,Atieno M,Lawn JE,et al.Long-term neurodevelopmental outcomes after intrauterine and neonatal insults:a systematic review[J].Lancet,2012,379(9814):445-452.DOI:10.1016/S0140-6736(11)61577-8.
2 Yan F,Zhang M,Meng Y,et al.Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis[J].Brain Res,2016,1651:104-113.DOI:10.1016/j.brainres.2016.09.024.
3 Larpthaveesarp A,Ferriero DM,Gonzalez FF.Growth factors for the treatment of ischemic brain injury (growth factor treatment)[J].Brain Sci,2015,5(2):165-177.DOI:10.3390/brainsci5020165.
4 Wei S,Luo C,Yu S,et al.Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway[J].Exp Cell Res,2017,361(2):342-352.DOI:10.1016/j.yexcr.2017.11.002.
5 Wu H,Zhao J,Chen M,et al.The anti-aging effect of erythropoietin via the erk/nrf2-are pathway in aging rats[J].J Mol Neurosci,2017,61(3):449-458.DOI:10.1007/s12031-017-0885-1.
6 Wu YW,Bauer LA,Ballard RA,et al.Erythropoietin for neuroprotection in neonatal encephalopathy:safety and pharmacokinetics[J].Pediatrics,2012,130(4):683-691.DOI:10.1542/peds.2012-0498.
7 Fauchere JC,Dame C,Vonthein R,et al.An approach to using recombinant erythropoietin for neuroprotection in very preterm infants[J].Pediatrics,2008,122(2):375-382.DOI:10.1542/peds.2007-2591.
8 Song J,Sun H,Xu F,et al.Recombinant human erythropoietin improves neurological outcomes in very preterm infants[J].Ann Neurol,2016,80(1):24-34.DOI:10.1002/ana.24677.
9 Natalucci G,Latal B,Koller B,et al.Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years:a randomized clinical trial[J].JAMA,2016,315(19):2079-2085.DOI:10.1001/jama.2016.5504.
10 Juul SE,Comstock BA,Wadhawan R,et al.A randomized trial of erythropoietin for neuroprotection in preterm infants[J].N Engl J Med,2020,382(3):233-243.DOI:10.1056/NEJMoa1907423.
11 Kellert BA,Mcpherson RJ,Juul SE.A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats[J].Pediatr Res,2007,61(4):451-455.DOI:10.1203/pdr.0b013e3180332cec.
12 Gonzalez FF,Larpthaveesarp A,Mcquillen P,et al.Erythropoietin increases neurogenesis and oligodendrogliosis of subventricular zone precursor cells after neonatal stroke[J].Stroke,2013,44(3):753-758.DOI:10.1161/stroke-aha.111.000104.
13 Ohls RK,Christensen RD,Widness JA,et al.Erythropoiesis stimulating agents demonstrate safety and show promise as neuroprotective agents in neonates[J].J Pediatr,2015,167(1):10-12.DOI:10.1016/j.jpeds.2015.03.054.
14 Kandasamy Y,Kumar P,Hartley L.The effect of erythropoietin on the severity of retinopathy of prematurity[J].Eye (Lond),2014,28(7):814-818.DOI:10.1038/eye.2014.95.
15 Shiou SR,Yu Y,Chen S,et al.Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis[J].J Biol Chem,2011,286(14):12123-12132.DOI:10.1074/jbc.M110.154625.
16 Davies A,Wassink G,Bennet L,et al.Can we further optimize therapeutic hypothermia for hypoxic-ischemic encephalopathy?[J].Neural Regen Res,2019,14(10):1678-1683.DOI:10.4103/1673-5374.257512.
17 Wu YW,Mathur AM,Chang T,et al.High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy:a phase ii trial[J].Pediatrics,2016,137(6):e20160191.DOI:10.1542/peds.2016-0191.
18 Yust-Katz S,Fisher-Shoval Y,Barhum Y,et al.Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress[J].Cytotherapy,2012,14(1):45-55.DOI:10.3109/14653249.2011.613928.
19 Donega V,Nijboer CH,Van Tilborg G,et al.Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury[J].Exp Neurol,2014,261:53-64.DOI:10.1016/j.expneurol.2014.06.009.
20 Berger R,S?der S.Neuroprotection in preterm infants[J].Biomed Res Int,2015,2015:257139.DOI:10.1155/2015/257139.
21 Rosell A,Morancho A,Navarro-Sobrino M,et al.Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice[J].PLoS ONE,2013,8(9):e73244.DOI:10.1371/journal.pone.0073244.
22 Phillips AW,Johnston MV,Fatemi A.The potential for cell-based therapy in perinatal brain injuries[J].Transl Stroke Res,2013,4(2):137-148.DOI:10.1007/s12975-013-0254-5.
23 Yoshimoto M,Koenig JM.Stem cells:potential therapy for neonatal injury?[J].Clin Perinatol,2015,42(3):597-612.DOI:10.1016/j.clp.2015.04.008.
24 Amable PR,Teixeira MV,Carias RB,et al.Protein synthesis and secretion in human mesenchymal cells derived from bone marrow,adipose tissue and Wharton’s jelly[J].Stem Cell Res Ther,2014,5(2):53-65.DOI:10.1186/scrt442.
25 Vinukonda G,Liao Y,Hu F,et al.Human cord blood-derived unrestricted somatic stem cell infusion improves neurobehavioral outcome in a rabbit model of intraventricular hemorrhage[J].Stem Cells Transl Med,2019,8(11):1157-1169.DOI:10.1002/sctm.19-0082.
26 Fang B,Wang H,Sun XJ,et al.Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits[J].J Vasc Surg, 2013,58(4):1043-1052.DOI:10.1016/j.jvs.2012.11.087.
27 McDonald CA,Djuliannisaa Z,Petraki M,et al.Intranasal delivery of mesenchymal stromal cells protects against neonatal hypoxic-ischemic brain injury[J].Int J Mol Sci,2019,20(10):2449.DOI:10.3390/ijms20102449.
28 Ahn SY,Chang YS,Sung DK,et al.Optimal route for mesenchymal stem cells transplantation after severe intraventricular hemorrhage in newborn rats[J].PLoS One,2015,10(7):e0132919.DOI:10.1371/journal.pone.0132919.
29 Ahn SY,Chang YS,Park WS.Stem cells for neonatal brain disorders[J]. Neonatology,2016,109(4):377-383.DOI:10.1159/000444905.
30 van Velthoven CT,Kavelaars A,van Bel F,et al.Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain[J].Brain Behav Immun, 2011,25(7):1342-1348.DOI:10.1016/j.bbi.2011.03.021.
31 Tamura G,Inagaki T.Removal of a minimal amount of subdural hematoma is effective and sufficient for term neonates with severe symptomatic spontaneous parenchymal hemorrhage[J].Childs Nerv Syst,2019,35(11):2237-2240.DOI:10.1007/s00381-019-04114-2.

相似文献/References:

[1]宁岩松,张供.婴儿主动脉弓阻塞病变的外科治疗[J].临床小儿外科杂志,2010,9(06):407.
 NING Yan song,ZHANG Gong,Surgical management of aortic arch obstruction associated with cardiac anomalies in infants.[J].Journal of Clinical Pediatric Surgery,2010,9(09):407.
[2]杜朝峻,丁力,胡英超,等.手术治疗婴幼儿法洛四联症83例[J].临床小儿外科杂志,2010,9(06):413.
 DU Chao jun,DING Li,HU Ying chao,et al.Surgical treatment of Tetralogy of Fallot in infancy: Experiences of 83 cases.[J].Journal of Clinical Pediatric Surgery,2010,9(09):413.
[3]贾杰,胡祖荣,邓恋,等.瑞芬太尼复合七氟醚在新生儿全身麻醉中的应用[J].临床小儿外科杂志,2010,9(06):464.
[4]郑珊Basnet Anupama黄焱磊陈莲肖现民.新生儿全结肠巨结肠阑尾壁内神经元标记物和神经支配分布的评价[J].临床小儿外科杂志,2011,10(01):0.
 ZHENG Shan,Basnet Anupama,HUANG Yan lei,et al.Evaluation of neuronal markers and innervations distribution in TCA appendix.[J].Journal of Clinical Pediatric Surgery,2011,10(09):0.
[5]江峰赵阳孙莲萍金惠明马杰.婴幼儿阻塞性脑积水两种手术方式的疗效比较[J].临床小儿外科杂志,2011,10(01):0.
 JIANG Feng,ZHAO Yang,SUN Liang ping,et al.Endoscopic third ventricul ostomy versus ventricul operitoneal shunt:clinical study of obstructive hydro cephalus in infants.[J].Journal of Clinical Pediatric Surgery,2011,10(09):0.
[6]马黎明褚衍林乔衍礼武广华李平萍张来住刘宏生程前进李祥张洪宇陈国庆郑善光刘高利安国营孙卓祥董海新.IL-6、TNF-α及sICAM-1在婴幼儿体外循环肺损伤中的表达及超滤干预效果[J].临床小儿外科杂志,2011,10(01):0.
[7]尹鉴淳 徐万华 李守林 王 浩 刘晓东.新生儿先天性重度肾积水诊疗分析[J].临床小儿外科杂志,2010,9(02):0.
[8]陈 快 戴康临 罗 鸣 邓庆强 陶 强 黄金狮.新生儿胃肠穿孔78例诊治分析[J].临床小儿外科杂志,2010,9(02):0.
[9]王鹏高翟波罗淑颖.婴幼儿室间隔缺损合并肺动脉高压的外科治疗[J].临床小儿外科杂志,2010,9(03):0.
[10]陈快戴康临罗鸣邓庆强陶强黄金狮.新生儿胃肠穿孔78例诊治分析[J].临床小儿外科杂志,2010,9(03):0.

备注/Memo

收稿日期:2020-04-05。
基金项目:重庆市科委基础科学与前沿技术研究重点项目(编号:cstc2015jcyjBX0144)
通讯作者:翟瑄,zhaixuan@163.com

更新日期/Last Update: 1900-01-01